Randomised controlled trials and real word evidence have consistently shown that GLP-1 receptor agonists are effective and ...

Struggles with obesity are a longstanding issue for millions of Americans and thousands of Iowans, but recent advancements in ...

Glucagon-like peptide 1 receptor agonists and fenofibrates may protect patients with type 2 diabetes against diabetic macular ...

Individual usage of glucagon like peptide 1 receptor agonists reduced the risk of hospitalization due to alcohol and substance use disorders.

But weight loss alone does not explain the drugs’ benefits. Both Holst and Sattar pointed to a discontinued GLP-1 drug once ...

Initial research has focused on obesity, but Ozempic, Wegovy and Mounjaro may potentially be used for addiction, heart ...

Elon Musk, one of President-elect Donald Trump’s closest confidants, revealed Wednesday his support for weight-loss drugs ...

A panelist discusses how glucagon-like peptide-1 receptor (GLP-1) agonists' cardioprotective effects likely stem from multiple physiological mechanisms, including reduced inflammation, improved ...

November 2024 has seen a variety of biotech deals take place to advance therapies across different stages in development.

Mangione, 26, was arrested Monday in connection with the murder of Brian Thompson outside an investor conference at a Hilton ...

We all have unique schedules, challenges, and responsibilities. But there’s one thing almost everyone can relate to while ...

Also in today’s newsletter, US to unveil new tariffs on Chinese cleantech imports, and North Korea slams South’s Yoon over failed martial law gambit ...